Plozasiran reduces triglyceride levels in mixed hyperlipidemia
1. In this randomized controlled trial, among patients with mixed hyperlipidemia, plozasiran significantly reduced fasting triglyceride levels compared with placebo. ...
Tag: hyperlipidemia
Assessment of lipid biomarker distribution in dried blood spots for newborn screening
1. In a retrospective cohort study, the distribution of low density lipoprotein cholesterol (LDL-C) and apolipoprotein B (ApoB) levels obtained ...
Combination-drug therapy and earlier detection recommended to improve outcomes in heterozygous familial hypercholesterolemia
1. A significantly greater proportion of patients receiving 2-3 lipid lowering medications achieved LDL-cholesterol targets compared to those receiving monotherapy. ...
#VisualAbstract: Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
1. Inclisiran, a small interfering RNA, therapy was shown to significantly lower levels of low-density lipoprotein (LDL) cholesterol compared to ...
Insclisiran significantly decreases LDL cholesterol in heterozygous familial hypercholesterolemia patients
1. Inclisiran, a small interfering RNA, therapy was shown to significantly lower levels of low-density lipoprotein (LDL) cholesterol compared to ...
#VisualAbstract: Polypill for Cardiovascular Disease Prevention in an Underserved Population
1. In this randomized, controlled trial, patients without cardiovascular disease randomized to receive a polypill containing atorvastatin, amlodipine, losartan, and ...
Polypill effective for blood pressure and cholesterol control in vulnerable population
1. In this randomized, controlled trial, patients without cardiovascular disease randomized to receive a polypill containing atorvastatin, amlodipine, losartan, and ...
Quick Take: Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome
1. The risk of major cardiovascular events may be further reduced with the addition of fenofibrate therapy to statin treatment ...
Quick Take: Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil
In low and middle-income countries, the implementation of evidence-based therapies for cardiovascular disease, including the use of statins, antiplatelet therapy ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
